U.S. Markets
Merck (MRK) said the study met its primary endpoint of clinical remission according to the Modified Mayo Score at week 12, as well as key secondary endpoints
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
